Abstract
Autoimmune pancreatitis (AIP) is a distinct type of chronic pancreatitis with unique clinical, pathological, serological, and imaging features. AIP usually presents with obstructive jaundice. Imaging studies often reveal enlargement of the pancreas with a pancreatic mass and strictures of the main pancreatic duct. Two subtypes of AIP have recently been identified. Type I AIP is more prevalent in elderly Asian males and is characterized by lymphoplasmacytic sclerosing pancreatitis, obliterative phlebitis, and infiltration of large numbers of IgG4-positive plasma cells. Type II AIP is more prevalent in Caucasians and is characterized by granulocyte epithelial lesions. Most patients with type I AIP have a significantly elevated serum IgG4 concentration, which is an important feature for diagnosis and for differentiating between AIP and other conditions such as pancreatic cancer. Extrapancreatic complications are common, such as sclerosing cholangitis, sclerosing sialadenitis, retroperitoneal fibrosis in type I AIP, and ulcerative colitis in type II AIP. A rapid response to glucocorticoids treatment is suggestive of AIP, but the relapse rate is high, warranting the use of immunosuppressant treatment. B-cell depletion with rituximab may be a promising therapy. The prognosis of AIP is generally benign if treated promptly, and spontaneous remission occurs in a proportion of patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sarles H, Sarles J C, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? Am J Dig Dis, 1961, 6: 688–698
Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci, 1995, 40: 1561–1568
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med, 2001, 344: 732–738
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol, 2003, 38: 982–984
Comings D E, Skubi K B, van Eyes J, et al. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel’s thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med, 1967, 66: 884–892
Chari S T, Longnecker D S, Kloppel G. The diagnosis of autoimmune pancreatitis: a western perspective. Pancreas, 2009, 38: 846–848
Chari S T, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus docu ment. Pancreas, 2010, 39: 549–554
Shimosegawa T, Chari S T, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas, 2011, 40: 352–358
Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol, 2011, 35: 26–35
Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol, 2007, 42: 6–8
Sah R P, Pannala R, Chari S T, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol, 2010, 8: 91–96
Hardacre J M, Iacobuzio-Donahue C A, Sohn T A, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg, 2003, 237: 853–858
Yadav D, Notahara K, Smyrk T C, et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol, 2003, 1: 129–135
Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch, 2004, 445: 552–563
Dhall D, Suriawinata A A, Tang L H, et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol, 2010, 41: 643–652
Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas, 2003, 27: 235–238
Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol, 2010, 45: 249–265
Stone J H, Khosroshahi A, Hilgenberg A, et al. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum, 2009, 60: 3139–3145
Kamisawa T, Takuma K, Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol, 2010, 7: 401–409
Sah R P, Chari S T. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol, 2011, 23: 108–113
Raina A, Greer J B, Whitcomb D C. Serology in autoimmune pancreatitis. Minerva Gastroenterol Dietol, 2008, 54: 375–387
Tabata T, Kamisawa T, Takuma K, et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta, 2009, 408: 25–28
Ghazale A, Chari S T, Smyrk T C, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol, 2007, 102: 1646–1653
Strehl J D, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol, 2011, 64: 237–243
Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut, 2009, 58: 1504–1507
Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med, 2006, 45: 497–501
Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med, 2009, 361: 2135–2142
Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology, 2000, 118: 573–581
Nishimori I, Miyaji E, Morimoto K, et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut, 2005, 54: 274–281
Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas, 2006, 33: 20–26
Endo T, Takizawa S, Tanaka S, et al. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes, 2009, 58: 732–737
Takizawa S, Endo T, Wanjia X, et al. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun, 2009, 386: 192–196
Takahashi N, Fletcher J G, Fidler J L, et al. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol, 2008, 190: 280–286
Sahani D V, Kalva S P, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology, 2004, 233: 345–352
Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol, 2010, 105: 1870–1875
Sugumar A, Levy M J, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut, 2011, 60: 666–670
Levy M J, Reddy R P, Wiersema M J, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc, 2005, 61: 467–472
Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol, 2006, 41: 626–631
Chari S T, Smyrk T C, Levy M J, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol, 2006, 4: 1010–1016
Kwon S, Kim M H, Choi E K. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas, 2007, 34: 279–286
Otsuki M, Chung J B, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol, 2008, 43: 403–408
Raina A, Krasinskas A M, Greer J B, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med, 2008, 132: 48–53
Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med, 2008, 47: 151–155
Kamisawa T, Chung J B, Irie H, et al. Japan-Korea symposium on autoimmune pancreatitis (KOKURA 2007). Pancreas, 2007, 35: 281–284
Ko S B, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology, 2010, 138: 1988–1996
Ghazale A, Chari S T, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology, 2008, 134: 706–715
Topazian M, Witzig T E, Smyrk T C, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol, 2008, 6: 364–366
Khosroshahi A, Bloch D B, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum, 2010, 62: 1755–1762
Ghazale A, Chari S T. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut, 2007, 56: 1650–1652
Khosroshahi A, Stone J H. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol, 2011, 23: 67–71
Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol, 2007, 42: 50–58
Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut, 2007, 56: 1719–1724
Naitoh I, Nakazawa T, Ohara H, et al. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clin ical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med, 2009, 48: 2003–2007
Church N I, Pereira S P, Deheragoda M G, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol, 2007, 102: 2417–2425
Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc, 2007, 66: 1142–1151
Raissian Y, Nasr S H, Larsen C P, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol, 2011, 22: 1343–1352
Sah R P, Chari S T, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology, 2010, 139: 140–148
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Wang, Q., Zhang, X. & Zhang, F. Autoimmune pancreatitis: current concepts. Sci. China Life Sci. 56, 246–253 (2013). https://doi.org/10.1007/s11427-013-4450-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4450-z